Belviq® was first approved by the Food and Drug Administration in 2012 and sold to consumers in 2013 as a way to help users manage their weight. Clinical trials have now shown a link between Belviq, also known as lorcaserin, and certain types of cancer.
We believe that anyone harmed by this medication has the right to compensation for the damages they’re experiencing. If you’ve been diagnosed with cancer after taking lorcaserin, contact our team today to schedule a free consultation.
The Link Between Belviq and Cancer
The FDA recalled Belviq in February 2020 after discovering an association between the medication and cancer. The three types of cancer most closely linked to Belviq are pancreatic, lung, and colorectal cancers.
The manufacturer of Belviq, Eisai Co., has yet to agree with the FDA’s assessment that the risks of Belviq outweigh the potential benefits for weight management. But Eisai Co. has complied with the FDA’s request to recall the drug.
The seven-year gap between the sell and recall of Belviq means that far too many consumers were put at risk by Eisai’s dangerous product. For those who have been diagnosed with cancer after taking Belviq, legal options are available.
Cancer Patients Who Took Belviq Should Explore Their Legal Options
Anyone who took Belviq and is now living with lung, pancreatic, or colorectal cancer has the right to consider legal action against Eisai Co. By filing a drug injury claim, these cancer patients can recover compensation that helps them with all past and future damages caused by Belviq.
Drug manufacturers have a responsibility to ensure the safety of their products. When they fall short of that obligation, they should be held accountable for the costs facing consumers who trusted the safety of their products.
Contact Our Team Today to Schedule a Free Consultation
We have years of experience getting compensation for people injured by the negligence of manufacturers. Let us help you find a path forward.
If you or someone you love took lorcaserin and has since been diagnosed with cancer, you should explore your legal options. Contact our team today to schedule a free, no-obligation case assessment.
Belviq® is a registered trademark of Arena Pharmaceuticals. The reference to the registered trademarks of Arena Pharmaceuticals is used here only for the purpose of identifying the product in question.
This law firm is not affiliated with, sponsored by or associated with Arena Pharmaceuticals, Eisai Co., or the FDA.
Do not stop taking a prescription medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death.
Cases may be referred to another attorney or law firm.
